Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
Coronavirus
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Business
STAT+

A digital medicine company tries to adopt pharma’s patent game. Will it work?

  • Rebecca Robbins

By Rebecca Robbins April 13, 2018

Reprints
Akili screenshot
A screenshot from one of Akili's video games. Akili Interactive Labs

In biopharma, patents are everything. In tech? Not so much.

Which is why it was unusual to see a company that’s trying to turn software into medicine announce this week that it’s bagged several patents.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Judge rules CVS, Walgreens, and Walmart owe $650M in…
Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suit
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Why you get paid to donate plasma but not…
Why you get paid to donate plasma but not blood
Bluebird wins U.S. approval for a gene therapy to…
Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder
‘A blind eye’: NIH fails to ensure clinical trial…
‘A blind eye’: NIH fails to ensure clinical trial results are reported, and still funds researchers…
Virtual Event – Biomarkers: The Foundation of Personalized Oncology
Virtual Event – Biomarkers: The Foundation of Personalized Oncology

Recommended Stories